PHILLIP MD ET AL FROST Insider Trading Transactions
Get free email notifications about insider trading for PHILLIP MD ET AL FROST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PHILLIP MD ET AL FROST. PHILLIP MD ET AL FROST is 10% Owner in VECTOR GROUP LTD ($VGR) and 10% Owner in NON INVASIVE MONITORING SYSTEMS INC /FL/ ($NIMU) and CEO & Chairman in Opko Health, Inc. ($EXEG) and 10% Owner in Tiger X Medical, Inc. ($CLIK) and in LADENBURG THALMANN FINANCIAL SERVICES INC. ($LTS) and 10% Owner in LADENBURG THALMANN FINANCIAL SERVICES INC. ($LTS) and Director in LADENBURG THALMANN FINANCIAL SERVICES INC ($LTS) and in Sevion Therapeutics, Inc. ($SVON) and Director in Sevion Therapeutics, Inc. ($SVON) and Director in Castle Brands Inc ($ROX) and in Cocrystal Pharma, Inc. ($BZNE) and Director in Cocrystal Pharma, Inc. ($COCP) and 10% Owner in IDI, Inc. ($IDI) and Director in IDI, Inc. ($IDI) and 10% Owner in Red Violet, Inc. ($RDVT).
Latest Insider Trading Transactions of PHILLIP MD ET AL FROST
Sentiment: All, BCDA, ROX, COCP, ELOX, FLNT, LTS, NIMU, EXEG, RDVT, VGR
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 31 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 12 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.02 | 1,800 | 5,436 | 2,869,427 | 2.9 M to 2.9 M (+0.06 %) |
Apr 12 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.01 | 200 | 602 | 2,867,627 | 2.9 M to 2.9 M (+0.01 %) |
Apr 11 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.08 | 10,000 | 30,800 | 2,867,427 | 2.9 M to 2.9 M (+0.35 %) |
Apr 11 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.07 | 14,327 | 43,984 | 2,857,427 | 2.8 M to 2.9 M (+0.50 %) |
Apr 11 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.03 | 10,000 | 30,300 | 2,843,100 | 2.8 M to 2.8 M (+0.35 %) |
Apr 11 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.01 | 2,200 | 6,622 | 2,833,100 | 2.8 M to 2.8 M (+0.08 %) |
Apr 10 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.10 | 1,800 | 5,580 | 2,830,900 | 2.8 M to 2.8 M (+0.06 %) |
Apr 10 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.07 | 1,000 | 3,070 | 2,829,100 | 2.8 M to 2.8 M (+0.04 %) |
Apr 10 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.05 | 20,000 | 61,000 | 2,828,100 | 2.8 M to 2.8 M (+0.71 %) |
Apr 10 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.04 | 34,700 | 105,488 | 2,808,100 | 2.8 M to 2.8 M (+1.25 %) |
Apr 10 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.03 | 10,000 | 30,300 | 2,773,400 | 2.8 M to 2.8 M (+0.36 %) |
Apr 10 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.02 | 2,500 | 7,550 | 2,763,400 | 2.8 M to 2.8 M (+0.09 %) |
Apr 10 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.01 | 10,000 | 30,100 | 2,760,900 | 2.8 M to 2.8 M (+0.36 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.14 | 10,000 | 31,400 | 2,750,900 | 2.7 M to 2.8 M (+0.36 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.12 | 10,000 | 31,200 | 2,740,900 | 2.7 M to 2.7 M (+0.37 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.11 | 10,000 | 31,100 | 2,730,900 | 2.7 M to 2.7 M (+0.37 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.09 | 8,700 | 26,883 | 2,720,900 | 2.7 M to 2.7 M (+0.32 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.09 | 1,300 | 4,011 | 2,712,200 | 2.7 M to 2.7 M (+0.05 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.08 | 15,400 | 47,432 | 2,710,900 | 2.7 M to 2.7 M (+0.57 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.08 | 800 | 2,460 | 2,695,500 | 2.7 M to 2.7 M (+0.03 %) |
Apr 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.07 | 3,800 | 11,666 | 2,694,700 | 2.7 M to 2.7 M (+0.14 %) |
Apr 06 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 10,000 | 32,500 | 2,690,900 | 2.7 M to 2.7 M (+0.37 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.04 | 33,579 | 102,080 | 2,680,900 | 2.6 M to 2.7 M (+1.27 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.04 | 15,650 | 47,498 | 2,647,321 | 2.6 M to 2.6 M (+0.59 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.03 | 5,777 | 17,504 | 2,631,671 | 2.6 M to 2.6 M (+0.22 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.01 | 5,000 | 15,050 | 2,625,894 | 2.6 M to 2.6 M (+0.19 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.00 | 34,600 | 103,800 | 2,620,894 | 2.6 M to 2.6 M (+1.34 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.00 | 900 | 2,696 | 2,586,294 | 2.6 M to 2.6 M (+0.03 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.99 | 11,500 | 34,385 | 2,585,394 | 2.6 M to 2.6 M (+0.45 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.99 | 100 | 299 | 2,573,894 | 2.6 M to 2.6 M (0.00 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.99 | 400 | 1,194 | 2,573,794 | 2.6 M to 2.6 M (+0.02 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.98 | 494 | 1,472 | 2,573,394 | 2.6 M to 2.6 M (+0.02 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.97 | 13,350 | 39,650 | 2,572,900 | 2.6 M to 2.6 M (+0.52 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.97 | 1,685 | 5,003 | 2,559,550 | 2.6 M to 2.6 M (+0.07 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.97 | 1,550 | 4,596 | 2,557,865 | 2.6 M to 2.6 M (+0.06 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.96 | 5,015 | 14,844 | 2,556,315 | 2.6 M to 2.6 M (+0.20 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.95 | 3,000 | 8,850 | 2,551,300 | 2.5 M to 2.6 M (+0.12 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.94 | 9,100 | 26,754 | 2,548,300 | 2.5 M to 2.5 M (+0.36 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.94 | 100 | 294 | 2,539,200 | 2.5 M to 2.5 M (0.00 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.94 | 1,200 | 3,522 | 2,539,100 | 2.5 M to 2.5 M (+0.05 %) |
Apr 04 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.93 | 10,000 | 29,300 | 2,537,900 | 2.5 M to 2.5 M (+0.40 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.13 | 5,000 | 15,650 | 2,527,900 | 2.5 M to 2.5 M (+0.20 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.12 | 9,500 | 29,640 | 2,522,900 | 2.5 M to 2.5 M (+0.38 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.12 | 500 | 1,558 | 2,513,400 | 2.5 M to 2.5 M (+0.02 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.11 | 4,500 | 13,995 | 2,512,900 | 2.5 M to 2.5 M (+0.18 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.11 | 500 | 1,553 | 2,508,400 | 2.5 M to 2.5 M (+0.02 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.10 | 10,000 | 31,000 | 2,507,900 | 2.5 M to 2.5 M (+0.40 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.07 | 17,572 | 53,946 | 2,497,900 | 2.5 M to 2.5 M (+0.71 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.07 | 900 | 2,761 | 2,480,328 | 2.5 M to 2.5 M (+0.04 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.07 | 1,528 | 4,683 | 2,479,428 | 2.5 M to 2.5 M (+0.06 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.06 | 8,700 | 26,622 | 2,477,900 | 2.5 M to 2.5 M (+0.35 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.06 | 100 | 306 | 2,469,200 | 2.5 M to 2.5 M (0.00 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.06 | 1,200 | 3,666 | 2,469,100 | 2.5 M to 2.5 M (+0.05 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.03 | 8,800 | 26,664 | 2,467,900 | 2.5 M to 2.5 M (+0.36 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.03 | 1,200 | 3,630 | 2,459,100 | 2.5 M to 2.5 M (+0.05 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.02 | 9,000 | 27,180 | 2,457,900 | 2.4 M to 2.5 M (+0.37 %) |
Mar 29 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.02 | 1,000 | 3,015 | 2,448,900 | 2.4 M to 2.4 M (+0.04 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 4,200 | 13,902 | 2,447,900 | 2.4 M to 2.4 M (+0.17 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 800 | 2,644 | 2,443,700 | 2.4 M to 2.4 M (+0.03 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 16,400 | 53,956 | 2,442,900 | 2.4 M to 2.4 M (+0.68 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 100 | 329 | 2,426,500 | 2.4 M to 2.4 M (0.00 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 2,100 | 6,899 | 2,426,400 | 2.4 M to 2.4 M (+0.09 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 8,100 | 26,568 | 2,424,300 | 2.4 M to 2.4 M (+0.34 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 1,900 | 6,223 | 2,416,200 | 2.4 M to 2.4 M (+0.08 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.26 | 11,500 | 37,490 | 2,414,300 | 2.4 M to 2.4 M (+0.48 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.26 | 400 | 1,302 | 2,402,800 | 2.4 M to 2.4 M (+0.02 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 3,700 | 12,025 | 2,402,400 | 2.4 M to 2.4 M (+0.15 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 1,300 | 4,219 | 2,398,700 | 2.4 M to 2.4 M (+0.05 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.24 | 3,000 | 9,705 | 2,397,400 | 2.4 M to 2.4 M (+0.13 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.23 | 100 | 323 | 2,394,400 | 2.4 M to 2.4 M (0.00 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.23 | 2,100 | 6,783 | 2,394,300 | 2.4 M to 2.4 M (+0.09 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.23 | 900 | 2,905 | 2,392,200 | 2.4 M to 2.4 M (+0.04 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.23 | 4,500 | 14,513 | 2,391,300 | 2.4 M to 2.4 M (+0.19 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 5,000 | 16,100 | 2,386,800 | 2.4 M to 2.4 M (+0.21 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.21 | 1,200 | 3,852 | 2,381,800 | 2.4 M to 2.4 M (+0.05 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.21 | 300 | 962 | 2,380,600 | 2.4 M to 2.4 M (+0.01 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.21 | 3,500 | 11,218 | 2,380,300 | 2.4 M to 2.4 M (+0.15 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.20 | 2,000 | 6,400 | 2,376,800 | 2.4 M to 2.4 M (+0.08 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.20 | 3,000 | 9,585 | 2,374,800 | 2.4 M to 2.4 M (+0.13 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 7,500 | 23,850 | 2,371,800 | 2.4 M to 2.4 M (+0.32 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 500 | 1,589 | 2,364,300 | 2.4 M to 2.4 M (+0.02 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 2,000 | 6,350 | 2,363,800 | 2.4 M to 2.4 M (+0.08 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 2,800 | 9,100 | 2,361,800 | 2.4 M to 2.4 M (+0.12 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 900 | 2,923 | 2,359,000 | 2.4 M to 2.4 M (+0.04 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 1,300 | 4,219 | 2,358,100 | 2.4 M to 2.4 M (+0.06 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 5,000 | 16,100 | 2,356,800 | 2.4 M to 2.4 M (+0.21 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 1,900 | 6,042 | 2,351,800 | 2.3 M to 2.4 M (+0.08 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 4,100 | 13,018 | 2,349,900 | 2.3 M to 2.3 M (+0.17 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.17 | 5,264 | 16,687 | 2,345,800 | 2.3 M to 2.3 M (+0.22 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.17 | 200 | 634 | 2,340,536 | 2.3 M to 2.3 M (+0.01 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.17 | 100 | 317 | 2,340,336 | 2.3 M to 2.3 M (0.00 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.16 | 4,436 | 14,018 | 2,340,236 | 2.3 M to 2.3 M (+0.19 %) |
Mar 26 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 10,000 | 32,750 | 2,335,800 | 2.3 M to 2.3 M (+0.43 %) |
Mar 26 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 5,000 | 16,350 | 2,325,800 | 2.3 M to 2.3 M (+0.22 %) |
Mar 26 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.26 | 10,000 | 32,600 | 2,320,800 | 2.3 M to 2.3 M (+0.43 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.39 | 5,000 | 16,950 | 2,310,800 | 2.3 M to 2.3 M (+0.22 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 3,400 | 11,390 | 2,305,800 | 2.3 M to 2.3 M (+0.15 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 1,600 | 5,352 | 2,302,400 | 2.3 M to 2.3 M (+0.07 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 3,600 | 11,916 | 2,300,800 | 2.3 M to 2.3 M (+0.16 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 100 | 331 | 2,297,200 | 2.3 M to 2.3 M (0.00 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 1,300 | 4,297 | 2,297,100 | 2.3 M to 2.3 M (+0.06 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.30 | 100 | 330 | 2,295,800 | 2.3 M to 2.3 M (0.00 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.30 | 100 | 330 | 2,295,700 | 2.3 M to 2.3 M (0.00 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 4,600 | 15,134 | 2,295,600 | 2.3 M to 2.3 M (+0.20 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 200 | 657 | 2,291,000 | 2.3 M to 2.3 M (+0.01 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 8,712 | 28,575 | 2,290,800 | 2.3 M to 2.3 M (+0.38 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 200 | 656 | 2,282,088 | 2.3 M to 2.3 M (+0.01 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 1,088 | 3,563 | 2,281,888 | 2.3 M to 2.3 M (+0.05 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.39 | 9,700 | 32,883 | 2,280,800 | 2.3 M to 2.3 M (+0.43 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.39 | 300 | 1,016 | 2,271,100 | 2.3 M to 2.3 M (+0.01 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 8,250 | 27,885 | 2,270,800 | 2.3 M to 2.3 M (+0.36 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 400 | 1,351 | 2,262,550 | 2.3 M to 2.3 M (+0.02 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 1,350 | 4,556 | 2,262,150 | 2.3 M to 2.3 M (+0.06 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 8,100 | 27,297 | 2,260,800 | 2.3 M to 2.3 M (+0.36 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 1,000 | 3,368 | 2,252,700 | 2.3 M to 2.3 M (+0.04 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 900 | 3,029 | 2,251,700 | 2.3 M to 2.3 M (+0.04 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.45 | 3,706 | 12,786 | 2,250,800 | 2.2 M to 2.3 M (+0.16 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.45 | 300 | 1,034 | 2,247,094 | 2.2 M to 2.2 M (+0.01 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.45 | 994 | 3,424 | 2,246,794 | 2.2 M to 2.2 M (+0.04 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.40 | 5,000 | 17,000 | 2,245,800 | 2.2 M to 2.2 M (+0.22 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 2,500 | 8,425 | 2,240,800 | 2.2 M to 2.2 M (+0.11 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 9,800 | 32,830 | 2,238,300 | 2.2 M to 2.2 M (+0.44 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 200 | 669 | 2,228,500 | 2.2 M to 2.2 M (+0.01 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 8,700 | 28,884 | 2,228,300 | 2.2 M to 2.2 M (+0.39 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 600 | 1,991 | 2,219,600 | 2.2 M to 2.2 M (+0.03 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 2,900 | 9,614 | 2,219,000 | 2.2 M to 2.2 M (+0.13 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 17,700 | 58,587 | 2,216,100 | 2.2 M to 2.2 M (+0.81 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 100 | 331 | 2,198,400 | 2.2 M to 2.2 M (0.00 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 9,800 | 32,242 | 2,198,300 | 2.2 M to 2.2 M (+0.45 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 200 | 657 | 2,188,500 | 2.2 M to 2.2 M (+0.01 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 2,500 | 8,200 | 2,188,300 | 2.2 M to 2.2 M (+0.11 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 8,100 | 26,487 | 2,185,800 | 2.2 M to 2.2 M (+0.37 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 500 | 1,634 | 2,177,700 | 2.2 M to 2.2 M (+0.02 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 1,400 | 4,571 | 2,177,200 | 2.2 M to 2.2 M (+0.06 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.54 | 9,000 | 31,860 | 2,175,800 | 2.2 M to 2.2 M (+0.42 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.54 | 4,000 | 14,140 | 2,166,800 | 2.2 M to 2.2 M (+0.18 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.53 | 4,000 | 14,120 | 2,162,800 | 2.2 M to 2.2 M (+0.19 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.52 | 3,300 | 11,616 | 2,158,800 | 2.2 M to 2.2 M (+0.15 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.52 | 100 | 352 | 2,155,500 | 2.2 M to 2.2 M (0.00 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.52 | 1,600 | 5,624 | 2,155,400 | 2.2 M to 2.2 M (+0.07 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.50 | 2,000 | 7,000 | 2,153,800 | 2.2 M to 2.2 M (+0.09 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.49 | 4,800 | 16,752 | 2,151,800 | 2.1 M to 2.2 M (+0.22 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.49 | 200 | 697 | 2,147,000 | 2.1 M to 2.1 M (+0.01 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.47 | 2,000 | 6,940 | 2,146,800 | 2.1 M to 2.1 M (+0.09 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.46 | 8,900 | 30,794 | 2,144,800 | 2.1 M to 2.1 M (+0.42 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.46 | 100 | 346 | 2,135,900 | 2.1 M to 2.1 M (0.00 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 6,579 | 22,237 | 2,135,800 | 2.1 M to 2.1 M (+0.31 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 600 | 2,027 | 2,129,221 | 2.1 M to 2.1 M (+0.03 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 2,821 | 9,521 | 2,128,621 | 2.1 M to 2.1 M (+0.13 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.36 | 2,600 | 8,736 | 2,125,800 | 2.1 M to 2.1 M (+0.12 %) |